These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 19588248
21. Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents. Satoh H, Takeuchi K. Curr Med Chem; 2012; 19(1):82-9. PubMed ID: 22300080 [Abstract] [Full Text] [Related]
22. Sulforaphane protects small intestinal mucosa from aspirin/NSAID-induced injury by enhancing host defense systems against oxidative stress and by inhibiting mucosal invasion of anaerobic enterobacteria. Yanaka A, Sato J, Ohmori S. Curr Pharm Des; 2013; 19(1):157-62. PubMed ID: 22950492 [Abstract] [Full Text] [Related]
23. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs. Takeuchi K, Yokota A, Tanaka A, Takahira Y. Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022 [Abstract] [Full Text] [Related]
24. Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid. Takeuchi K, Hase S, Mizoguchi H, Komoike Y, Tanaka A. J Physiol Paris; 2001 Jul; 95(1-6):51-7. PubMed ID: 11595418 [Abstract] [Full Text] [Related]
25. Peyer's patches play a protective role in nonsteroidal anti-inflammatory drug-induced enteropathy in mice. Hiyama S, Iijima H, Shinzaki S, Inoue T, Shiraishi E, Kawai S, Araki M, Kato M, Hayashi Y, Nishida T, Fujii H, Mukai A, Shibata N, Sato S, Kiyono H, Gotoh K, Motooka D, Nakamura S, Iida T, Tsujii M, Takehara T. Inflamm Bowel Dis; 2014 May; 20(5):790-9. PubMed ID: 24651581 [Abstract] [Full Text] [Related]
26. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors. Hayashi S, Kurata N, Yamaguchi A, Amagase K, Takeuchi K. J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141 [Abstract] [Full Text] [Related]
27. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats. Nishio H, Hayashi Y, Terashima S, Takeuchi K. Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018 [Abstract] [Full Text] [Related]
28. Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice. Imaoka H, Ishihara S, Kazumori H, Kadowaki Y, Aziz MM, Rahman FB, Ose T, Fukuhara H, Takasawa S, Kinoshita Y. Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G311-9. PubMed ID: 20508157 [Abstract] [Full Text] [Related]
29. Suppression of contractile activity in the small intestine by indomethacin and omeprazole. Lichtenberger LM, Bhattarai D, Phan TM, Dial EJ, Uray K. Am J Physiol Gastrointest Liver Physiol; 2015 May 01; 308(9):G785-93. PubMed ID: 25721304 [Abstract] [Full Text] [Related]
30. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat. Menozzi A, Pozzoli C, Giovannini E, Solenghi E, Grandi D, Bonardi S, Bertini S, Vasina V, Coruzzi G. Eur J Pharmacol; 2006 Dec 15; 552(1-3):143-50. PubMed ID: 17069793 [Abstract] [Full Text] [Related]
31. [Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug. (3) Damaging effects on the gastrointestinal tract]. Ono N, Yamasaki Y, Yamamoto N, Sunami A, Miyake H. Nihon Yakurigaku Zasshi; 1986 Sep 15; 88(3):205-13. PubMed ID: 3098653 [Abstract] [Full Text] [Related]
32. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K. J Pharmacol Exp Ther; 2002 Dec 15; 303(3):1248-54. PubMed ID: 12438549 [Abstract] [Full Text] [Related]
33. Present status and strategy of NSAIDs-induced small bowel injury. Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, Tokioka S, Arakawa T. J Gastroenterol; 2009 Dec 15; 44(9):879-88. PubMed ID: 19568687 [Abstract] [Full Text] [Related]
34. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats. Kamei K, Kubo Y, Kato N, Hatazawa R, Amagase K, Takeuchi K. Dig Dis Sci; 2008 Oct 15; 53(10):2657-66. PubMed ID: 18306037 [Abstract] [Full Text] [Related]
37. Processed Aloe vera gel attenuates non-steroidal anti-inflammatory drug (NSAID)-induced small intestinal injury by enhancing mucin expression. Kim MW, Kang JH, Shin E, Shim KS, Kim MJ, Lee CK, Yoon YS, Oh SH. Food Funct; 2019 Sep 01; 10(9):6088-6097. PubMed ID: 31490512 [Abstract] [Full Text] [Related]
38. Protective effect of lactosucrose on intracolonic indomethacin-induced small-intestinal ulcers in rats. Honda K, Matsumoto T, Kuroki F, Iida M, Oka M, Sawatani I. Scand J Gastroenterol; 1999 Mar 01; 34(3):264-9. PubMed ID: 10232870 [Abstract] [Full Text] [Related]
39. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Pozzoli C, Menozzi A, Grandi D, Solenghi E, Ossiprandi MC, Zullian C, Bertini S, Cavestro GM, Coruzzi G. Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan 01; 374(4):283-91. PubMed ID: 17151854 [Abstract] [Full Text] [Related]
40. Role of bile in pathogenesis of indomethacin-induced enteropathy. Jacob M, Foster R, Sigthorsson G, Simpson R, Bjarnason I. Arch Toxicol; 2007 Apr 01; 81(4):291-8. PubMed ID: 17151867 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]